Gene Expression Profiling Reveals Clear Differences Between EBV-Positive and EBV-Negative Posttransplant Lymphoproliferative Disorders - Wikidata - thesis-toulmin - TriplyDB

Gene Expression Profiling Reveals Clear Differences Between EBV-Positive and EBV-Negative Posttransplant Lymphoproliferative Disorders

Gene Expression Profiling Reveals Clear Differences Between EBV-Positive and EBV-Negative Posttransplant Lymphoproliferative Disorders

http://www.wikidata.org/entity/Q58063835

about

Posttransplant lymphoproliferative disease after pediatric solid organ transplantation Recent insights in the pathogenesis of post-transplantation lymphoproliferative disorders Post-transplant lymphoproliferative disorders are not associated with IgG4 sclerosing disease.Molecular signature of Epstein Barr virus-positive Burkitt lymphoma and post-transplant lymphoproliferative disorder suggest different roles for Epstein Barr virus.How do viruses trick B cells into becoming lymphomas?EBV-driven B-cell lymphoproliferative disorders: from biology, classification and differential diagnosis to clinical management.The presence of Epstein-Barr virus significantly impacts the transcriptional profile in immunodeficiency-associated Burkitt lymphoma.Epstein-Barr virus positive diffuse large B-cell lymphoma predict poor outcome, regardless of the age.Gene expression meta-analysis reveals immune response convergence on the IFNγ-STAT1-IRF1 axis and adaptive immune resistance mechanisms in lymphoma HLA Associations and Risk of Posttransplant Lymphoproliferative Disorder in a Danish Population-Based Cohort.The Epstein Barr-encoded BART-6-3p microRNA affects regulation of cell growth and immuno response in Burkitt lymphoma Molecular pathogenesis of B-cell posttransplant lymphoproliferative disorder: what do we know so far?Virus-encoded microRNA contributes to the molecular profile of EBV-positive Burkitt lymphomas EBV-Positive and EBV-Negative Posttransplant Diffuse Large B Cell Lymphomas Have Distinct Genomic and Transcriptomic Features.Mutational landscape of B-cell post-transplant lymphoproliferative disorders.B-Cell and Classical Hodgkin Lymphomas Associated With Immunodeficiency: 2015 SH/EAHP Workshop Report-Part 2.Identification of distinct subgroups of EBV-positive post-transplant diffuse large B-cell lymphoma.HLA and Risk of Diffuse Large B cell Lymphoma After Solid Organ Transplantation.The Impact of EBV Status on Characteristics and Outcomes of Posttransplantation Lymphoproliferative Disorder.Occurrence and prognostic relevance of CD30 expression in post-transplant lymphoproliferative disorders.EBV-negative monomorphic B-cell post-transplant lymphoproliferative disorders are pathologically distinct from EBV-positive cases and frequently contain TP53 mutations.A population-based study of 135 lymphomas after solid organ transplantation: The role of Epstein-Barr virus, hepatitis C and diffuse large B-cell lymphoma subtype in clinical presentation and survival.Post-transplant molecularly defined Burkitt lymphomas are frequently MYC-negative and characterized by the 11q-gain/loss pattern.Development of lymphoma from the donor of haploidentical stem cell transplantation: A case report.Posttransplant lymphoproliferative disorders in kidney transplant recipients: a retrospective cohort analysis over two decades in Hong Kong.Comprehensive review of post-organ transplant hematologic cancers.Posttransplant Lymphoproliferative Disorder After Clinical Islet Transplantation: Report of the First Two Cases.Post-transplant lymphoproliferative disorder: a heterogeneous conundrum - response to Weisenburger DD & Gross TG.Epstein-Barr virus-associated lymphomas EBV infection determines the immune hallmarks of plasmablastic lymphoma

P2860

Q26866013-36E603CE-E8BC-49BF-A830-D9B4D415826C Q28075701-731BC69D-06CC-4EB8-B091-DA9E2F9EC30C Q30303135-795CED8B-795E-4ED6-9D7F-B8B7EA24051D Q30610963-29FFDB21-2EA3-431D-8E6E-F5E342077D3E Q34020096-74795B15-D322-442E-866E-C8598F9C357B Q35040644-A0F0BBA7-E86E-4A94-B557-7160F55809E7 Q35711180-B5E5F456-6BDB-4E02-B1A1-1C69920964B3 Q35880791-F13CFBE8-A9DF-43EB-93E4-00B52DEE7965 Q36051184-12084159-AF36-45BC-8AA8-1EB04C5D5312 Q37097738-06DD6277-2D9F-42DC-A994-93229F2E3D5D Q37733947-B81BA9C2-31FA-49B4-8058-623E69859B4A Q38108302-1200362C-1EDC-4AA3-BECC-21547AF3BA2D Q38296711-35C2225E-A8EC-44AE-802F-C50486BF405E Q40094003-9D04BCED-602D-4D07-B013-6AC6AF3B6461 Q40238236-A3782627-F745-4049-A187-CE865079E93F Q40250056-951F50AB-1AFF-40E0-8A3A-C14533E9C02C Q40383136-10F8F338-504D-41CD-BC8E-24576047B57F Q40492215-DA18BEB8-2614-4EBB-A042-37BE34EB567C Q41219311-A118E2C3-5FD2-40FB-9C5F-C7362CAFA97D Q41728703-0A579E5D-70AD-455E-BAF4-434024C85544 Q42051829-37619DFE-CAC4-43AB-9297-1517C9099446 Q42242814-EAD51F8B-A5BC-451D-8C6B-676A97846DE5 Q42384503-4ABD8C36-1647-4C94-9987-6A41EF1F21D3 Q47130854-28A787AC-CBF4-4316-B38D-175C63C77D3A Q47148062-D2D5028C-8B32-4C3A-B230-AD2F49CC1843 Q47572480-2535BCB2-31E4-49A1-AFE4-5E58E290604E Q47799831-D60F4DC3-5D48-4FFF-BFF7-2D9B16EFE287 Q53722637-7AFB6008-7C09-4069-8235-A5BD7B80C606 Q56930876-C8BF651B-96D5-4640-B6A0-44C1A6D0ED44 Q56968100-DB12A060-8E2E-43D5-83EF-55BD9E18A644

P2860

Gene Expression Profiling Reveals Clear Differences Between EBV-Positive and EBV-Negative Posttransplant Lymphoproliferative Disorders

http://www.wikidata.org/entity/Q58063835

description

article

@en

im März 2013 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в березні 2013

@uk

name

Gene Expression Profiling Reve ...... Lymphoproliferative Disorders

@en

Gene Expression Profiling Reve ...... Lymphoproliferative Disorders

@nl

type

label

Gene Expression Profiling Reve ...... Lymphoproliferative Disorders

@en

Gene Expression Profiling Reve ...... Lymphoproliferative Disorders

@nl

prefLabel

Gene Expression Profiling Reve ...... Lymphoproliferative Disorders

@en

Gene Expression Profiling Reve ...... Lymphoproliferative Disorders

@nl

P1433

Q58063835-BE4CFA96-9839-4F45-A30C-DFF092DD2EF4

P1476

Q58063835-B6E27F24-FAB2-437C-950B-54EA6CF38AE6

P2093

Q58063835-1467D9B0-E620-4960-BC87-92D86ED8B10F

Q58063835-14A2D7B6-D736-407F-82A7-F223621196E6

Q58063835-4D3D40C4-EB4F-4B4B-A3E9-5C9917B271FC

Q58063835-64FDEB07-19F1-4BFC-9CE1-7F560D0B5FB3

Q58063835-6BAB7F92-22B0-4C87-8BB4-D0355D71C7D6

Q58063835-720914B1-C038-4EB1-A28F-18EB763CAA45

Q58063835-7E7F0926-306A-4CFB-8770-A00FB1690B3D

Q58063835-9D847BD5-B4E1-46E4-A653-BC49D23E912E

Q58063835-AA8C745E-B9D7-491D-9D74-9368434C7D6E

Q58063835-E0F6B58D-E53C-4986-8D32-833368E6B362

P2860

Q58063835-09BE4C08-7DAF-42DC-AB10-330ABE267974

Q58063835-14DBB213-1EAF-4192-A147-DB99DEA8621C

Q58063835-30DEB8F5-4168-4906-8A51-E32B8EB9BECC

Q58063835-41FCC12E-4843-4E00-B02E-D65C37DC0DDD

Q58063835-430DDD88-EDF2-43D3-9F7F-16E417AAF5FB

Q58063835-50D46706-1590-45D2-8AB4-F708DDE0A0AB

Q58063835-52416CF4-BE82-4040-8F4D-606E223AD72A

Q58063835-5CD49988-A37F-4679-9846-D142C3CB1B80

Q58063835-8DBE4D79-107F-473C-A4C2-42069C280478

Q58063835-A02CFEE4-6E8E-40B8-879E-26F1689D804A

P304

Q58063835-C98EF73A-8A78-449B-9764-C82F9143F874

P31

Q58063835-70E4F992-680E-4EC1-9472-671E30E6244E

P356

Q58063835-75427D16-6224-454C-AEF5-260A57BDFD51

P407

Q58063835-53996BCB-524A-4DD3-A665-CCD4BF363533

P433

Q58063835-7AC4C686-1AA4-47E6-B709-99F87EBB5C06

P478

Q58063835-03604260-B2F4-4A8F-9CD8-4E32E55F93D4

P50

Q58063835-34DDB9CC-ADB6-418D-ABD4-CFF3B429A218

Q58063835-58117800-9A04-446B-ADEF-935635FA361C

Q58063835-BF6C2689-802F-4F68-B040-BB4267B15E88

P577

Q58063835-5F68D10F-4EB2-4CE5-9079-BED22EF2F1CE

P698

Q58063835-900DD593-EA32-42FF-9FE7-3D91E59B8BA4

P356

P1433

American Journal of Transplantation

P1476

Gene expression profiling reve ...... lymphoproliferative disorders

@en

P2093

A Herreman

http://www.w3.org/2001/XMLSchema#string

C De Wolf-Peeters

http://www.w3.org/2001/XMLSchema#string

D Dierickx

http://www.w3.org/2001/XMLSchema#string

E Bittoun

http://www.w3.org/2001/XMLSchema#string

G Verhoef

http://www.w3.org/2001/XMLSchema#string

I Wlodarska

http://www.w3.org/2001/XMLSchema#string

J F Ferreiro

http://www.w3.org/2001/XMLSchema#string

J Morscio

http://www.w3.org/2001/XMLSchema#string

T Tousseyn

http://www.w3.org/2001/XMLSchema#string

X Sagaert

http://www.w3.org/2001/XMLSchema#string

P2860

A novel human gene encoding HECT domain and RCC1-like repeats interacts with cyclins and is potentially regulated by the tumor suppressor proteins

Molecular characterization of human CD94: a type II membrane glycoprotein related to the C-type lectin superfamily

The human MCP-2 gene (SCYA8): cloning, sequence analysis, tissue expression, and assignment to the CC chemokine gene contig on chromosome 17q11.2

The interferon stimulated gene 54 promotes apoptosis

Characterization of a novel gene (NKG7) on human chromosome 19 that is expressed in natural killer cells and T cells

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

Macrophage inflammatory protein-1

IL-1Rrp is a novel receptor-like molecule similar to the type I interleukin-1 receptor and its homologues T1/ST2 and IL-1R AcP

P304

1305-1316

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/AJT.12196

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Patrick Matthys

P577

2013-03-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23489474

http://www.w3.org/2001/XMLSchema#string